These outcomes, along with a past report demonstrating that a small-molecule ACKR3 agonist CCX771 displays anxiolytic-like behavior in mice,2 aid the strategy of targeting ACKR3 as a singular solution to modulate the opioid system, which could open new therapeutic avenues for opioid-similar Conditions. Identify your selection: Name should be https://alainn257pkg6.newsbloger.com/profile